Dyspnea following intravenous drug use

Dyspnea following intravenous drug use

Bibliographic Details
Main Authors:	E. Matrosovich, R. Brodmann, S. Lampert, G. Lehnert, A. Hartmann, J.H. Ficker
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	Respiratory Medicine Case Reports
Subjects:	Pulmonary foreign-body granulomas Pulmonary fibrosis Pulmonary talcosis Pulmonary talc-granulomatosis Interstitial lung disease Pulmonary hypertension
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213007116301770

Similar Items

Pulmonary Talcosis Due to Daily Inhalation of Talc Powder
by: Guillaume Verlynde, et al.
Published: (2018-01-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
by: Raj Parikh, et al.
Published: (2022-10-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

The PH‐ILD Detection tool: External validation and use in patients with ILD
by: Raj Parikh, et al.
Published: (2023-07-01)

Wegener′s granulomatosis disease mimicking pulmonary tuberculosis
by: Naveen Pandhi, et al.
Published: (2015-01-01)

Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease
by: Hiroki Nakayama, et al.
Published: (2023-07-01)

Idiopathic pulmonary fibrosis with complication of severe respiratory failure, right heart failure, and steroid induced diabetes – qualification for lung transplantation as a matter of urgency
by: Beata P. Kraśnicka-Sokół, et al.
Published: (2016-09-01)

Lung Damage in Rheumatoid Arthritis—A Retrospective Study
by: Georgiana Dinache, et al.
Published: (2022-12-01)

Pulmonary schistosomiasis in a young male: A case report and review of the literature
by: Waseem M Hajjar, et al.
Published: (2018-01-01)

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
by: Zachary A. Haynes, et al.
Published: (2023-10-01)

Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis
by: Natalia V. Trushenko, et al.
Published: (2023-06-01)

Lung surfactant in subacute pulmonary disease
by: Spragg Roger G, et al.
Published: (2002-04-01)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
by: Carla R. Copeland, et al.
Published: (2021-10-01)

Irreversible Respiratory Failure in a Full-Term Infant with Features of Pulmonary Interstitial Glycogenosis as Well as Bronchopulmonary Dysplasia
by: Maresa E. C. Jiskoot-Ermers, et al.
Published: (2015-06-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
by: Justin M. Oldham, et al.
Published: (2017-08-01)

Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
by: André Carramenha de Góes Hirano, et al.
Published: (2017-06-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
by: Kazuya Ichikado, et al.
Published: (2023-06-01)

Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England
by: Ann Morgan, et al.
Published: (2023-07-01)

Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
by: Esam H. Alhamad, et al.
Published: (2020-11-01)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
by: Steven D. Nathan, et al.
Published: (2024-01-01)

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis
by: Christopher Thomas, et al.
Published: (2023-04-01)

Symptomatic relief through Ayurveda treatment in the patient of interstitial lung disease
by: Palak Sanjeev Singhal, et al.
Published: (2023-01-01)

Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation
by: Enric Domingo, et al.
Published: (2017-05-01)

The impact of emphysema in pulmonary fibrosis
by: Vincent Cottin
Published: (2013-06-01)

Lung involvement in childhood onset granulomatosis with polyangiitis
by: Giovanni Filocamo, et al.
Published: (2017-04-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
by: Shelsey W. Johnson, et al.
Published: (2022-07-01)

Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
by: Ruchika A. Sangani, et al.
Published: (2022-10-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
by: Wei Yan, et al.
Published: (2015-01-01)

Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights
by: Grégoire Ruffenach, et al.
Published: (2020-11-01)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
by: Barbara Ruaro, et al.
Published: (2022-10-01)

Predictors of Progression and Mortality in Patients with Chronic Hypersensitivity Pneumonitis: Retrospective Analysis of Registry of Fibrosing Interstitial Lung Diseases
by: Natalia V. Trushenko, et al.
Published: (2023-02-01)

Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
by: Yifan Lin, et al.
Published: (2022-05-01)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
by: Amarpreet Kaur, et al.
Published: (2017-09-01)

Editorial: Fibrotic Lung Disease—“Lumping” the Progressive Phenotype
by: Tejaswini Kulkarni, et al.
Published: (2022-05-01)

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry
by: Christopher S. King, et al.
Published: (2023-08-01)

Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients
by: Ghanem Maha, et al.
Published: (2009-01-01)

Diagnostic and Therapeutic Challenges for Patients with Pulmonary Hypertension due to Lung Diseases
by: Laurent Godinas, et al.
Published: (2022-04-01)

The effect of cosmetic talc powder on health
by: Khaled Ali Al Awam, et al.
Published: (2019-01-01)